CGMP pharmaceutical scale-up - Part 4: Installation, commissioning, development

被引:0
|
作者
Pepper, C [1 ]
Patel, M [1 ]
Hartounian, H [1 ]
机构
[1] SkyePharma Inc, San Diego, CA 92121 USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:28 / +
页数:4
相关论文
共 50 条
  • [1] CGMP pharmaceutical scale-up - Part 1: Design
    Pepper, C
    Patel, M
    Hartounian, H
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1999, 12 (09): : 26 - +
  • [2] CGMP pharmaceutical scale-up - part 3: Automation
    Patel, M
    Pepper, C
    Hartounian, H
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1999, 12 (11): : 52 - 54
  • [3] CGMP pharmaceutical scale up - Part 2. Contractors and the request for proposal
    Pepper, C
    Patel, M
    Hartounian, H
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1999, 12 (10): : 36 - +
  • [4] Pharmaceutical Cocrystals: A Perspective on Development and Scale-up of Solution Cocrystallization
    Saha, Anindita
    Ahangar, Aadil A.
    Dar, Aijaz A.
    Thirunahari, Satyanarayana
    Parambil, Jose V.
    CRYSTAL GROWTH & DESIGN, 2023, 23 (11) : 7558 - 7581
  • [5] Scale-up of pharmaceutical spray drying using scale-up rules: A review
    Poozesh, Sadegh
    Bilgili, Ecevit
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 562 : 271 - 292
  • [6] Optimization and scale-up of pharmaceutical syntheses
    Les, Andrzei
    Szelejewski, Wieslaw
    PRZEMYSL CHEMICZNY, 2007, 86 (12): : 1174 - 1177
  • [7] Scale-up methodology for pharmaceutical spray drying
    Gil, Marco
    Vicente, Joao
    Gaspar, Filipe
    CHIMICA OGGI-CHEMISTRY TODAY, 2010, 28 (04) : 18 - 22
  • [8] Two Novel Pharmaceutical Cocrystals of a Development Compound - Screening, Scale-up, and Characterization
    Leung, Dennis H.
    Lohani, Sachin
    Ball, Richard G.
    Canfield, Nicole
    Wang, Yaling
    Rhodes, Timothy
    Bak, Annette
    CRYSTAL GROWTH & DESIGN, 2012, 12 (03) : 1254 - 1262
  • [9] Synthesis of Rovafovir Etalafenamide (Part I): Active Pharmaceutical Ingredient Process Development, Scale-Up, and Impurity Control Strategy
    Standley, Eric A.
    Bringley, Dustin A.
    Calimsiz, Selcuk
    Ng, Jeffrey D.
    Sarma, Keshab
    Shen, Jinyu
    Siler, David A.
    Ambrosi, Andrea
    Chang, Wen-Tau T.
    Chiu, Anna
    Davy, Jason A.
    Doxsee, Ian J.
    Esanu, Mihaela M.
    Garber, Jeffrey A. O.
    Kim, Youri
    Kwong, Bernard
    Lapina, Olga
    Leung, Edmund
    Lin, Lennie
    Martins, Andrew
    Phoenix, Jenny
    Phull, Jaspal
    Roberts, Benjamin J.
    Shi, Bing
    St-Jean, Olivier
    Wang, Xiang
    Wang, Li
    Wright, Nande
    Yu, Guojun
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2021, 25 (05) : 1215 - 1236
  • [10] Development and Scale-Up of a Continuous Reaction for Production of an Active Pharmaceutical Ingredient Intermediate
    McMullen, Jonathan P.
    Marton, Christopher H.
    Sherry, Benjamin D.
    Spencer, Glenn
    Kukura, Joseph
    Eyke, Natalie S.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2018, 22 (09) : 1208 - 1213